Interpace Diagnostics develops molecular diagnostic tests. You can be assured that all of the molecular tests They offer are driven by rigorous, validated science. They power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. The unique molecular diagnostic tests They offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.

Rosetta Genomics Ltd. is a molecular diagnostics company with offices in Israel and the United States that uses micro-ribonucleic acid (microRNA) biomarkers to develop diagnostic tests designed to differentiate between various types of cancer. The company expects the first three tests based on its technology to be submitted for regulatory approval in 2008. The diagnostic tests will differentiate between squamous and non-squamous non-small cell lung cancer (NSCLC); differentiate between adenocarcinoma and peritoneal mesothelioma; and seek to identify the origin of tumors in patients representing cancer of unknown primary (CUP). Using a single microRNA, the highly sensitive, highly specific test for squamous and non-squamous lung cancer has passed the prevalidation phase and has been submitted for approval to the New York State Department of Health Clinical Laboratory Evaluation Program in April 2008.

Cornell provides education about the earth and atmospheric sciences. They offer summer and winter sessions. Their students contact them through phone and email services.

Asuragen is a fully integrated diagnostics company focused on molecular oncology and early detection of cancer, with an emphasis on microRNA. Asuragen's current diagnostics product portfolio consists of Signature® Genetic and Oncology Testing products, as well as industry leading controls and standards engineered using its patented Armored RNA® technology. In addition to its diagnostics products, Asuragen offers GLP testing services and an established cGMP manufacturing facility that allow it to span the spectrum of discovery, testing, production and commercialization.

Pharmadesign, Inc. provides solutions for dispensing medication. The firm's services includes patient education, training models, injection training, packing and starter kits. The company was founded by Fred Pether in 1984 and is headquartered in Warren, NJ.

QIAGEN Gaithersburg, Inc., a subsidiary of QIAGEN NV, is an American company located in Gaithersburg, MD, that manufactures and supplies diagnostic devices.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Qingdao Changanda Pharmaceutical Co., Ltd., established on 2014-04-03, The business scope includes wholesale prepackaged food(The validity period of the food circulation license is subject to the license). Technology research and development of Chinese herbal medicine planting,technical consulting;wholesale:food,vegetable,flowers,fruit,non-packed seeds. (Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Bozhou New Health Technology Co., Ltd., established on 2015-12-18, The business scope includes the production and sales of medical devices;Production and sales of disinfection products;Wholesale of medical equipment(one type,Class II,Three categories);Experimental Research and Development of Medical Technology;Marketing of pharmaceutical and medical device products,academic promotion,Marketing Planning,Market Research Services;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

BASF AB supplies raw materials to paper, chemicals, and construction industries. Its products include construction chemical, crop protection products, dispersions and pigments, plastics, polyurethane systems and coating products. The company was founded in 1953 and is headquartered in Göteborg, Sweden.

FUJIFILM Wako Pure Chemical Corp. produces and wholesales clinical diagnostic reagents, electronic materials, and chemical products. The firm offers product information, laboratory chemicals, specialty chemicals, clinical diagnostic reagents and equipment. The company was founded in 1922 and is headquartered in Osaka, Japan.

Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals. The Genetically Modified Silkworm segment sells products using the cocoon of genetically modified silkworm. The Testing segment offers prevention and diagnostic support on top of drug discovery and research support in lifestyle-related diseases using lipid metabolism analysis technology. The Cosmetics-related segment develops and manufactures cosmetic products containing Neosilk-Human Collagen I. The company was founded on September 9, 1982 and is headquartered in Fujioka, Japan.